Keywords: Sanofi-Aventis, Jevtana, FDA, USA, Prostate cancer

US FDA approves second new treatment for advanced prostate cancer, Sanofi-Aventis’ Jevtana

Article | 18 June 2010

Print This

In another important breakthrough for prostate cancer patients, the US Food and Drug Administration yesterday gave its approval to French ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in